SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Boufi, M.
Right arrow Articles by Vayssairat, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boufi, M.
Right arrow Articles by Vayssairat, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Foot Gangrene in Patients with End-Stage Renal Disease: A Case Control Study

Mourad Boufi, MD

Department of Vascular Surgery and Research Unit of CNRS, UMR 7054, Tenon Hospital (Assistance Publique-Hôpitaux de Paris), University of Paris VI, Saint-Antoine Faculty of Medicine, Paris, France

Parinaz Ghaffari, MD

Unit of Vascular Medicine, UMR 7054, Tenon Hospital (Assistance Publique-Hôpitaux de Paris), University of Paris VI, Saint-Antoine Faculty of Medicine, Paris, France

Eric Allaire, PhD

Department of Vascular Surgery and Research Unit of CNRS, UMR 7054, Tenon Hospital (Assistance Publique-Hôpitaux de Paris), University of Paris VI, Saint-Antoine Faculty of Medicine, Paris, France

Hafedh Fessi, MD

Department of Nephrology and Research Unit of INSERM N°489, UMR 7054, Tenon Hospital (Assistance Publique-Hôpitaux de Paris), University of Paris VI, Saint-Antoine Faculty of Medicine, Paris, France

Pierre Ronco, MD

Department of Nephrology and Research Unit of INSERM N°489, UMR 7054, Tenon Hospital (Assistance Publique-Hôpitaux de Paris), University of Paris VI, Saint-Antoine Faculty of Medicine, Paris, France

Michel Vayssairat, MD

Unit of Vascular Medicine, UMR 7054, Tenon Hospital (Assistance Publique-Hôpitaux de Paris), University of Paris VI, Saint-Antoine Faculty of Medicine, Paris, France, michel.vayssairat{at}tnn.ap-hop-paris.fr

The prevalence of peripheral arterial disease (PAD) in patients with end-stage renal disease (ESRD) is high, with an annual risk of amputation estimated at 13%, and indications for limb revascularization in patients combining ESRD with stage IV PAD (foot gangrene) are still controversial. This case-controlled study compared survival, limb salvage, and quality of life in a group of patients hospitalized for foot gangrene according to their renal status (ESRD versus no renal insufficiency). All patients with ESRD hospitalized for foot gangrene (n=16) from 1996 to 2002 were compared with a control group with normal creatininemia (n=24) hospitalized for foot gangrene due to peripheral atherosclerotic arterial disease. The 2 groups were matched for age, sex ratio, and number with diabetes mellitus. After a mean follow-up of 467 ±410 days, patients with ESRD had a more severe prognosis as regards mortality (68.7% vs 12.5%, p=0.0005) and major amputation (31% versus 8%, p=0.09). The ESRD group was characterized by more frequent extensive arterial calcifications (16/16 vs 13/24, p=0.002), owing to a higher level of the calcium phosphorus product (3.54 ±1.2 vs 2.4 ±0.6, p=0.0023), and by impaired microcirculatory perfusion, as indicated by a lower oxygen pressure (TcPO2) (15.6 ±12 mm Hg vs 26 ±16, p=0.07). ESRD implies a poor prognosis in patients with stage IV peripheral arterial disease.

Angiology, Vol. 57, No. 3, 355-361 (2006)
DOI: 10.1177/000331970605700312


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement